SCHEMBL1012973

SCHEMBL1012973

Nc1cccc(OCc2ccco2)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.68
MAOB P27338 2/20 0.56
CYP3A4 P08684 3/20 0.51
TP53 P04637 1/20 0.51
APP P05067 1/20 0.51
TSHR P16473 1/20 0.45
ALDH1A1 P00352 2/20 0.43
POLB P06746 2/20 0.40
NPC1 O15118 1/20 0.40
HPGD P15428 1/20 0.40
CYP1A2 P05177 1/20 0.39
MAPK1 P28482 2/20 0.38
USP2 O75604 1/20 0.38
HSP90AA1 P07900 1/20 0.38
MAPT P10636 1/20 0.38
RAB9A P51151 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
SLC1A3 P43003 1/20 0.37
SLC1A2 P43004 1/20 0.37
SLC1A1 P43005 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8816431 0.81 GAA (1.00) GAAMAOBAPPTSHRALDH1A1
SCHEMBL1607082 0.78 GAA (0.70) GAATSHRALDH1A1POLBNPC1
SCHEMBL13439809 0.76 SOD1 (0.51) GAACYP3A4TP53TSHRALDH1A1
SCHEMBL9454126 0.76 MAOA (0.59) GAAMAOBALDH1A1POLBNPC1
SCHEMBL19770687 0.76 GAA (0.62) GAACYP3A4TP53TSHRALDH1A1
SCHEMBL7505965 0.75 NR4A2 (0.61) NPC1RAB9A
SCHEMBL1680709 0.75 GAA (0.70) GAAMAOBHPGD
SCHEMBL1013698 0.74 F2 (0.56) GAAMAOBTSHRALDH1A1HPGD
SCHEMBL8308770 0.73 GAA (0.58) GAATP53ALDH1A1POLBNPC1
Hydrochloric Acid SCHEMBL9454235 0.73 NOS1 (0.50) GAAALDH1A1POLBMAPK1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110054631-A Bromo- 4- chlorine furans [2,3-b] quinoline of 2-, derivative and synthetic method and application 中国药科大学 2019-07-26 CN disclosed
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 GAA 459/4885MAOB 565/4885CYP3A4 2543/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.